1. Home
  2. FNWD vs CCCC Comparison

FNWD vs CCCC Comparison

Compare FNWD & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Finward Bancorp

FNWD

Finward Bancorp

N/A

Current Price

$36.18

Market Cap

164.2M

Sector

Finance

ML Signal

N/A

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.70

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNWD
CCCC
Founded
1994
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.2M
185.1M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
FNWD
CCCC
Price
$36.18
$2.70
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$37.50
$12.20
AVG Volume (30 Days)
4.6K
2.2M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
1.32%
N/A
EPS Growth
N/A
16.45
EPS
1.88
N/A
Revenue
N/A
$35,947,000.00
Revenue This Year
$17.40
N/A
Revenue Next Year
$5.44
N/A
P/E Ratio
$19.31
N/A
Revenue Growth
N/A
1.02
52 Week Low
$26.46
$1.09
52 Week High
$39.99
$3.82

Technical Indicators

Market Signals
Indicator
FNWD
CCCC
Relative Strength Index (RSI) 45.32 52.95
Support Level $35.25 $2.26
Resistance Level $38.79 $2.85
Average True Range (ATR) 0.74 0.20
MACD -0.16 -0.04
Stochastic Oscillator 26.81 64.84

Price Performance

Historical Comparison
FNWD
CCCC

About FNWD Finward Bancorp

Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: